Definitive Contract 75D30119C05321
Award Date
7/15/19
Potential Completion Date
9/30/20
Potential Value
$275K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
University Of Texas System
NAICS Category
622110 - General Medical and Surgical Hospitals
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $345,790.34 firm fixed price contract from the Centers for Disease Control and Prevention (CDC) in Pittsburgh for the "LAMP STUDY HOUSTON" project. The contract has an ultimate completion date of May 31, 2024. UTHealth has extensive experience conducting biomedical and public health research under federal contracts and grants, frequently collaborating with other academic institutions and government...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the University of Texas Health Science Center at Houston (UTHealth), a state-controlled institution of higher learning, for an Elastomeric Respirator Study. The firm fixed-price contract has a potential value of $833,009.00 and a completion date of August 31, 2023. The contract is not set aside. As a prime contractor, UTHealth has provided research services,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Definitive Contract for $150,904.40 to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, for an "Invasive Mold Data Acquisition" project. The contract does not have a set-aside designation and was awarded on July 15, 2019, with a completion date of July 14, 2020. MD Anderson Cancer Center is a comprehensive cancer treatment...
This is a $449,000.00 definitive contract awarded by a U.S. government agency to the University of Texas Health Science Center at Houston (UTHealth), which is the prime contractor. The contract is a cost-no-fee type and does not have a set-aside designation. UTHealth is providing a range of healthcare research, clinical trials, data analytics, and administrative support services under this award. UTHealth is a comprehensive academic health university in Texas that frequently partners with...
This is a firm fixed price purchase order contract awarded by the National Institute for Minority Health and Disparities (NIMHD) to the University of Texas Health Science Center at Houston (UTHealth) for a Prospective Cohort Data Analyses Project. The $43,923 contract supports research services related to the NIMHD's mission. UTHealth, a state-controlled institution of higher learning, will provide the requested data analysis services. This contract award is not associated with a larger contract...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to the University of Texas Health Science Center at Houston (UTHealth) for library prep and next generation genome sequencing of influenza A virus. The contract has a potential value of $17,800.00 and a completion date of February 20, 2018. UTHealth is a U.S. Government Entity registered as an Educational...
This federal contract award is for a Definitive Contract with a ceiling value of $734,730.60 issued by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, a civilian agency. The contract was awarded to the University of Texas at Austin, a public research university, to perform work under Broad Agency Announcement (BAA) Topic 20.2 - "Estimating the Effects of COVID-19 Non-Pharmaceutical Interventions on the Burden of Influenza in the U.S." The University of Texas...
This federal contract award, valued at $906,699.00, was granted to the University of Texas Health Science Center at Houston (UTHealth) by the Shared Services Center, a civilian agency. The contract is for a research grant focused on the impacts of nighttime lighting in modern societies. As a state-controlled institution of higher learning, UTHealth has extensive capabilities in biomedical research, clinical trials, and translational science. The University of Texas System, the parent...
This federal contract award for $4,209,368.29 was made by the National Heart Lung and Blood Institute, part of the National Institutes of Health, to the University of Texas Health Science Center at Houston (UTHealth). The contract, titled "THE ANTIHYPERTENSIVE AND LIPID-LOWERING TO PREVENT HEART ATTACK TRIAL RENEWAL", does not have a set-aside designation and is a definitive contract with a cost-no-fee pricing type. UTHealth is a subcomponent of the larger University of Texas System,...
This is a $710,772.20 cost-no-fee definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the University of Texas Medical Branch at Galveston (UTMB) on June 1, 2021. The contract is for FY 21 BAA Topic 8 and has a completion date of October 30, 2022. UTMB is a medical institution that provides a wide range of services to the federal government, including biomedical research, clinical trials, medical training, public health...